Phase IB/II Trial Of Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
What is the purpose of this trial?
The purpose of this trial is to test a deescalated 3-fraction stereotactic body radiotherapy (SBRT) regimen to 45 Gray (Gy) in 3 fractions for centrally located thoracic tumors.
- Trial withYale Cancer Center
- Start Date05/28/2020
- End Date01/31/2030
- Last Updated07/30/2021
- Study HIC#2000025868